Regulation of Ceramide Biosynthesis by TOR Complex 2  by Aronova, Sofia et al.
Cell Metabolism
ArticleRegulation of Ceramide Biosynthesis
by TOR Complex 2
Sofia Aronova,1 Karen Wedaman,1 Pavel A. Aronov,2 Kristin Fontes,1 Karmela Ramos,1 Bruce D. Hammock,2
and Ted Powers1,*
1Section of Molecular and Cellular Biology, College of Biological Sciences
2Department of Entomology
University of California, Davis, Davis, CA 95616, USA
*Correspondence: tpowers@ucdavis.edu
DOI 10.1016/j.cmet.2007.11.015SUMMARY
Ceramides and sphingoid long-chain bases (LCBs)
are precursors to more complex sphingolipids and
play distinct signaling roles crucial for cell growth
and survival. Conserved reactions within the sphin-
golipid biosynthetic pathway are responsible for the
formation of these intermediates. Components of
target of rapamycin complex 2 (TORC2) have been
implicated in the biosynthesis of sphingolipids in
S. cerevisiae; however, the precise step regulated
by this complex remains unknown. Here we demon-
strate that yeast cells deficient in TORC2 activity are
impaired for de novo ceramide biosynthesis both
in vivo and in vitro. We find that TORC2 regulates
this step in part by activating the AGC kinase Ypk2
and that this step is antagonized by theCa2+/calmod-
ulin-dependent phosphatase calcineurin. Because
Ypk2 is activated independently by LCBs, the direct
precursors to ceramides, our data suggest a model
wherein TORC2 signaling is coupled with LCB levels
to control Ypk2 activity and, ultimately, regulate ce-
ramide formation.
INTRODUCTION
Complex sphingolipids are essential components of eukaryotic
membranes, where they play a variety of roles important for
cell signaling and intracellular trafficking (Cowart and Obeid,
2007; Dickson et al., 2006; Sims et al., 2004). In yeast, the early
steps of sphingolipid biosynthesis involve a number of important
metabolites, most notably (1) sphingoid long-chain bases
(LCBs), represented by dihydrosphingosine (DHS) and phytos-
phingosine (PHS); (2) the phosphorylated forms of these LCBs
(LCBPs), represented by DHS-P and PHS-P; and (3) dihydrocer-
amides and phytoceramides (DHS-ceramides and PHS-ceram-
ides, respectively) (Cowart and Obeid, 2007; Dickson et al.,
2006; Sims et al., 2004) (Figure 1). In particular, LCBs and LCBPs
have been identified as important mediators of heat stress (Dick-
son et al., 1997; Jenkins et al., 1997; Skrzypek et al., 1999; Zhang
et al., 2001). PHS also participates in activation of the kinases
Pkh1 and Pkh2, orthologs of mammalian PDK1, as well as their
downstream signaling partners, the AGC kinases Ypk1 and148 Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc.Ypk2 (Friant et al., 2001; Liu et al., 2005a; Sun et al., 2000). In
mammalian cells, ceramides have been implicated in diverse
functions such as apoptosis, inflammation, and aging, but the
roles of ceramides have not been well characterized in yeast
(Hannun and Obeid, 2002; Obeid and Hannun, 2003; Venable
et al., 1995). A sensitive balance exists between levels of LCBPs
versus ceramides that is believed to be crucial for normal cell
growth and survival (Hannun, 1996; Sims et al., 2004; Taha
et al., 2006). Remarkably, the regulation of this balance, often
referred to as the ‘‘ceramide/LCBP rheostat’’ (Kobayashi and
Nagiec, 2003; Spiegel, 2000), as well as of sphingolipid metabo-
lism in general, remains poorly characterized.
Previous studies have linked a number of regulatory proteins
to sphingolipid biosynthesis in yeast, including components of
the target of rapamycin (TOR) signaling network (Beeler et al.,
1998; Tabuchi et al., 2006). TOR is an evolutionarily conserved,
nutrient-regulated protein kinase that assembles into two dis-
tinct protein complexes, termed TOR complex 1 and 2 (TORC1
and TORC2) (Loewith et al., 2002; Reinke et al., 2004), of which
TORC1 is uniquely inhibited by the immunosuppressive drug ra-
pamycin (Loewith et al., 2002). Together, TORC1 and TORC2 in-
fluence a wide spectrum of cellular activities that are important
for temporal as well as spatial aspects of cell growth (Wulls-
chleger et al., 2006). An early study implicated two essential
components of TORC2 in sphingolipid biosynthesis, namely
Tor2 and Tsc11/Avo3 (referred to here as Avo3) (Beeler et al.,
1998), the latter of which is the ortholog of the mammalian
TORC2-specific component Rictor (Wullschleger et al., 2006).
Specifically, genes encoding Tor2 and Avo3 were identified in
a genetic screen for suppressors of a deletion of CSG2, whose
gene product is involved in conversion of inositol phosphorylcer-
amide (IPC) to mannosyl-IPC (MIPC) in a later step of the path-
way (Beeler et al., 1998) (Figure 1). The precise step affected
by these suppressors has not been determined, but they are
likely to act upstream of IPC formation because they suppress
the Ca2+ hypersensitivity of csg2D cells that results from the ac-
cumulation of IPC. More recently, Slm1 and Slm2, two proteins
that function downstream of TORC2 (Audhya et al., 2004),
have also been linked to CSG2 and to IPC formation (Tabuchi
et al., 2006). Whether these results can be explained by
TORC2 or its effectors acting at an earlier step within the sphin-
golipid biosynthetic pathway has not been addressed.
An important consideration in the studies cited above is that
temperature-sensitive mutants were employed that required
use of a nonpermissive temperature of 37C or higher, wherein
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and/or balance of sphingolipid biosynthetic intermediates (Dick-
son et al., 2006; Ferguson-Yankey et al., 2002). Herewe describe
the characterization of an allele of AVO3 (avo3-30) that is com-
promised for growth and sphingolipid metabolism at 30C. Liq-
uid chromatography-electrospray ionization tandemmass spec-
trometry (LC-ESI-MS/MS)-based profiling of sphingolipids in this
mutant reveals an important and positive role for TORC2 in the
regulation of ceramide biosynthesis. Our results suggest that
positive control of phytoceramide and dihydroceramide synthe-
sis by TORC2 is mediated by the AGC kinase Ypk2, an ortholog
of mammalian SGK and/or Akt/PKB that is a specific substrate
for TORC2 (Kamada et al., 2005). Based on our results, we
suggest a model wherein the TORC2 branch of TOR signaling
is coupled with PHS levels to control Ypk2 activity and, ulti-
mately, regulate ceramide production.
RESULTS
Isolation of a Temperature-Sensitive Allele of AVO3
To investigate the role of TORC2 in sphingolipid biosynthesis, we
isolated a temperature-sensitive (ts) allele of AVO3, termed
avo3-30, as described in Experimental Procedures. We chose
Figure 1. Simplified Schematic Diagram of the Sphingolipid Biosyn-
thetic Pathway in S. cerevisiae
Shown are some of the major intermediates of the pathway as well as a se-
lected set of genes encoding proteins required for specific steps of the
pathway considered here. Not shown is Ydc1, an alkaline ceramidase that
catabolizes DHS-ceramides.to focus on Avo3 rather than Tor2 because only the former is
found exclusively in TORC2 (Loewith et al., 2002; Reinke et al.,
2004). From among several avo3 mutants isolated, avo3-30
was unique in that it grew like wild-type at 25C but displayed
significant growth defects at both 30C and 37C (Figure 2A).
These growth defects were due specifically to mutations in
AVO3 because they were completely suppressed by introduc-
tion of a plasmid-expressed wild-type copy of the gene (Fig-
ure 2B). In addition to temperature-sensitive growth, avo3-30
cells displayed a number of phenotypes at 30C, similar to other
reported avo3 (Ho et al., 2005) and tor2 ts alleles (Helliwell et al.,
1998), suggestive of defects in cell integrity signaling, including
partial restoration of growth by inclusion of the osmotic stabilizer
sorbitol, hypersensitivity to rapamycin and caffeine, and depo-
larization of the actin cytoskeleton (Figure 2C; see also below).
The mutant was also hypersensitive to low concentrations of
myriocin, an inhibitor of serine palmitoyltransferase, which cata-
lyzes the first step in the sphingolipid biosynthetic pathway, as
well as aureobasidin A, an inhibitor of IPC synthase, consistent
with it playing a role within this biosynthetic pathway (Figure 2D).
Western blot analysis of extracts prepared from avo3-30 cells
demonstrated that there were diminished but stable levels of
mutant Avo3 protein at 30C but a drastic reduction following
prolonged incubation at 37C (Figure 2E), consistent with the
more severe growth phenotype observed at 37C (Figures 2A
and 2F). Also in agreement with these findings was the observa-
tion that sorbitol fails to rescue the growth of avo3-30 cells at
37C (Figure 2C). Taken together, we conclude from these
results that avo3-30 confers partial loss of function at 30C and
complete loss of function at 37C, most likely with respect to
TORC2 activity.
avo3-30 Cells Display Reduced Levels
of Major Ceramides
The growth defect observed in avo3-30 cells at 30C provided
an important and unique advantage for metabolic profiling of
sphingolipids in conditions free of heat stress encountered at
37C. Moreover, because no significant growth defect was ob-
served until approximately 5–6 hr following a shift to 30C, by
performing analyses at early time points we could be confident
that any differences observed in comparison to wild-type cells
were unlikely to be due to secondary effects associated with al-
tered growth rate (Figure 2F). We first applied this strategy to
examine the role of AVO3 in ceramide synthesis. Ceramides
in yeast are formed by N-acylation of sphingoid bases, primar-
ily phytosphingosine (PHS) but also dihydrosphingosine (DHS),
using C26-CoA and C24-CoA as preferred substrates (Cowart
et al., 2006; Guillas et al., 2003) (Figure 1). Accordingly, we first
used LC-MS/MS to measure absolute levels of C26-PHS and
C24-PHS ceramides in wild-type versus avo3-30 cells (see
Experimental Procedures). We observed that steady-state
levels of both phytoceramides were decreased 5- to 10-fold
in avo3-30 cells relative to wild-type following a 3 hr shift to
30C (p < 0.01; Figure 3A). Minor differences were also ob-
served at 25C, suggesting that avo3-30 cells possess a consti-
tutive defect in ceramide production at the permissive temper-
ature (Figure 3A). In addition to these results, we observed
a reduction in C26-DHS-ceramide in avo3-30 cells following
a shift to 30C (p < 0.01; see Figure S1A available online).Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc. 149
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Sensitive Allele of AVO3
(A) Phenotype of avo3-30 cells on solid medium. Wild-type
(WT; LHY291) and avo3-30 cells were streaked onto YPD
agar plates and incubated at the indicated temperatures for
2–3 days.
(B) The temperature-sensitive (ts) phenotype of avo3-30 is res-
cued by plasmid-expressed WT AVO3. WT and avo3-30 cells
were transformed with either the control vector pRS313
(Sikorski and Heiter, 1989) or pAVO3 and grown on SCD
agar plates lacking histidine at the indicated temperatures
for 2–3 days.
(C) Cell integrity-related phenotypes of avo3-30 cells. Cells
were streaked onto YPD agar plates or plates containing 0.8
M sorbitol (+Sorb), 1 mM caffeine (+Caff), or 0.2 mg/ml rapa-
mycin (+Rap) and incubated at 30C or 37C, as indicated.
(D) Hypersensitivity of avo3-30 cells to inhibitors of the sphin-
golipid biosynthetic pathway. Cells were streaked onto YPD
agar plates or plates containing 0.5 mM myriocin (+Myr) or 9
nM aureobasidin A (+Aur) and incubated at 25C.
(E) Protein levels of Avo3 in WT and avo3-30 cells. Cells were
grown at 25C and were either left at 25C or shifted to 30C
and 37C for a further 5 hr. Aliquots were collected each
hour and processed for western blot analysis. Tor1 protein
levels were analyzed as a loading control.
(F) Growth curves of WT and avo3-30 cells in liquid culture.
Cells were grown in YPD medium at 25C, diluted to
OD600 = 0.08, and shifted to 30
C or 37C for 8 hr. Growth
was monitored by A600, and growth curves were plotted on
a semilogarithmic scale.
C26-CoA and C24-CoA used in ceramide syn-
thesis are derived from shorter C18-CoA or C16-
CoA molecules by a series of fatty acid elongation
steps (Kohlwein et al., 2001) (Figure 1). Thus, we
considered the possibility that downregulation of
this elongation branch could account for the de-
creased levels of ceramides in avo3-30 cells de-
scribed above. If this were the case, we expected
to observe preferential accumulation of ceramides
containing shorter fatty acids in the avo3-30mutant
(Kohlwein et al., 2001). By contrast, however, we
observed that following a 3 hr shift to 30C, the
steady-state levels of both C18-PHS and C18-
DHS ceramides were significantly decreased in
avo3-30 cells relative to wild-type (p < 0.01;
Figure 3A; Figure S1A). A reduction, although less
prominent, was also observed in the levels of
C16-PHS andC16-DHS ceramides in avo3-30 cells
at 30C (Figures S1A and S1B).
Most ceramides undergo a-hydroxylation in their
fatty acid residues, in a reaction controlled by Scs7,
prior to incorporation into IPC (Dunn et al., 1998;
Haak et al., 1997) (Figure 1). We therefore next con-
sidered the possibility that the decrease in ceram-
ide levels in avo3-30 cells was a consequence of
upregulation of the a-hydroxylation step of the
pathway. If this were the case, we expected toWith respect to C24-DHS ceramide, this species could be de-
tected at low levels in wild-type cells but was not detectable in
avo3-30 cells at 30C (data not shown).observe preferential accumulation of a-hydroxylated ceramide
species in avo3-30 cells at 30C. By contrast, however, we ob-
served decreased levels of C26(OH)-PHS and C24(OH)-PHS
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TORC2 Regulates Ceramide BiosynthesisFigure 3. Monitoring Intermediates in the Sphingolipid Biosynthetic Pathway in Wild-Type and avo3-30 Cells
(A) Levels of phytoceramides were analyzed in extracts derived from WT and avo3-30 cells grown in YPD medium at 25C following a shift to 30C for 3 hr.
(B) Levels of LCBs (DHS and PHS) and LCBPs (DHS-P and PHS-P) were analyzed in extracts derived fromWT and avo3-30 cells in YPDmedium following a shift
to 30C for 3 hr.
(C) Levels of DHS and PHSwere analyzed in extracts derived fromWT, avo3-30, and avo3-30 lcb4D cells in YPDmedium following a shift to 30C for 3 hr. In (A–C),
error bars indicate the SD of separately extracted samples (n = 3).
(D) Monitoring ceramide synthesis in vitro. Microsomal membranes were isolated and ceramide synthase activity was measured as described in Experimental
Procedures. Left panel: schematic diagram of the in vitro reaction, showing the structure of the C18-SPHC17 ceramide product and the substrates SPHC17 and
C18-CoA used for this reaction. Right panel: C18-CoA concentration dependence of ceramide synthase activity in microsomal membranes isolated from WT
versus avo3-30 cells.relative to wild-type cells following a shift to 30C (Figure S1C).
Together with previous results placing TORC2 upstream of IPC
synthesis (Beeler et al., 1998), these findings suggested that
the reduction in ceramide levels in avo3-30 cells is due to a defect
prior to or at the step of ceramide formation. This conclusion is
consistent with previous findings showing that cells lacking
ceramide synthase fail to synthesize a-hydroxylated C26-PHS
(Guillas et al., 2001).
Reduction in Ceramide Levels in avo3-30 Cells Is Due to
a Defect Downstream of LCB Formation
Wenext considered the possibility that the reduction in ceramide
levels in avo3-30 cells is a consequence of limiting amounts ofceramide precursors, i.e., DHS and PHS (Figure 1). Accordingly,
we used LC-MS/MS to examine steady-state levels of both DHS
and PHS in avo3-30 cells. Because a dynamic balance exists
with respect to the levels of LCBs and their phosphorylated
forms (Hannun, 1996; Kobayashi and Nagiec, 2003; Spiegel
and Milstien, 2000) (Figure 1), we also monitored steady-state
levels of DHS-P and PHS-P. Intriguingly, following a shift to
30C for 3 hr, we observed a reproducible decrease in the levels
of both DHS and PHS (p < 0.01) and a corresponding increase in
the levels of DHS-P and PHS-P (p < 0.01and p < 0.05, respec-
tively) in avo3-30 cells relative to wild-type (Figure 3B). One
possible explanation for these results was that LCBs are formed
normally in avo3-30 cells at 30C but are preferentially shuntedCell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc. 151
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TORC2 Regulates Ceramide BiosynthesisFigure 4. Beneficial Effects of Deleting LCB4 and/or Adding Exogenous PHS with Respect to avo3-30 Phenotypes
(A and B) Growth in liquid YPD medium (A) and on YPD agar plates (B) of indicated strains in the absence or presence of different concentrations of PHS and at
different temperatures, as indicated.
(C) Effect of PHS addition on actin polarization in the indicated strains grown at 30C (upper panels). Bar graph represents the quantification of this experiment
and includes data for WT and avo3-30 cells grown at 25C for comparison.
(D) Influence of LCB4 deletion and/or PHS addition on viability of avo3-30 cells. The indicated strains were grown to early log phase in liquid media that either
lacked or contained the indicated concentration of PHS at 25C and were then transferred to 30C for 4 hr. Cultures were diluted and plated onto solid YPD
medium at 25C to determine colony-forming units (expressed as % of WT).152 Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc.
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preventing LCBP formation would result in accumulation of DHS
and/or PHS in avo3-30 cells. To test this prediction, we com-
bined the avo3-30 allele with a deletion of LCB4, which encodes
the major LCB kinase required for the synthesis of the majority of
LCBPs (Nagiec et al., 1998) (Figure 1). Indeed, we now observed
accumulation of LCBs, in particular PHS, in avo3-30 lcb4D cells
at 30C (p < 0.01; Figure 3C). No significant corresponding in-
crease in levels of phytoceramides was detected in the double
mutant, however, consistent with avo3-30 cells being impaired
at the step of ceramide synthesis (data not shown; see below).
avo3-30 Cells Have Reduced Ceramide Synthase
Activity In Vitro
To test directly whether ceramide synthesis is affected in avo3-
30 cells, we monitored ceramide formation in isolated micro-
somes in vitro. Previous studies havedemonstrated the feasibility
of this approach (Guillas et al., 2001, 2003; Kobayashi and
Nagiec, 2003; Schorling et al., 2001), which we modified in order
tomonitor ceramide formation usingLC-MS/MS (seeExperimen-
tal Procedures). As substrates, we used C18-CoA and an un-
natural C17 derivative of mammalian sphingosine (SPHC17)
(Figure 3D, left panel). We chose these substrates because the
expected product (C18-SPHC17 ceramide) is not produced in
yeast, which facilitates its identification within an expected back-
ground of endogenous ceramide species. A previous study has
demonstrated that sphingosine can be used as a substrate by
yeast ceramide synthase in vivo (Tani et al., 2006), which we
have confirmed is also the case for SPHC17 (unpublished data).
In membranes prepared from wild-type cells, we observed that
ceramide formation in this assay was linear over time (data not
shown) and reached a plateau at saturating concentrations of
C18-CoA (Figure 3D, right panel). The overall kinetic parameters
observed in this reaction were consistent with a previous study
using radiolabeled DHS as a substrate (Kobayashi and Nagiec,
2003). Remarkably, we consistently observed a reduction in ce-
ramide synthase activity of membranes prepared from tempera-
ture-shifted avo3-30 cells (Figure 3D, right panel).
Exogenous PHS Compensates for Diminished Levels
of Phytoceramides in avo3-30 Cells
Accumulation of LCBPs has previously been shown to correlate
with cell growth inhibition in yeast (Kim et al., 2000; Zhang et al.,
2001). In this regard, it is possible that accumulation of LCBPs in
avo3-30 cells contributes to the growth phenotype of this mu-
tant, based on our observation that deletion of LCB4 partially im-
proves its growth at 30C (Figures 4A and 4B). On the other hand,
deletion of LCB4 did not significantly improve actin polarization,
because similar defectswere observed in both avo3-30 aswell as
avo3-30 lcb4D cells at 30C (Figure 4C). Remarkably, we found
that addition of exogenous PHS significantly rescued defects
in actin polarization in both avo3-30 and, to a greater extent,
avo3-30 lcb4D cells (Figure 4C). Moreover, exogenous PHS par-
tially improved the growth of avo3-30 cells and significantly im-
proved the growth of avo3-30 lcb4D cells at 30C (Figures 4Aand 4B). Simultaneous deletion of LCB4 and addition of PHS
also largely restored the viability of avo3-30 cells when shifted
to 30C (Figure 4D). That PHS addition was more efficacious
when added to avo3-30 lcb4D versus avo3-30 cells is presum-
ably related to the fact that it cannot be converted efficiently to
PHS-P in the former strain. Deletion of LCB4 and/or PHS addi-
tion could partially restore growth of avo3-30 cells at 35C but
not 37C, indicating that these conditions can compensate for
a partial but not complete loss of function of AVO3 (Figure 4B).
Interestingly, we observed that addition of PHS following a tem-
perature shift to 30C resulted in a minor but statistically signifi-
cant restoration of ceramide levels in avo3-30 lcb4D cells relative
to lcb4D control cells (p < 0.01; Figure 4E). Thus, it is possible
that the positive effects of adding exogenous PHS are due to
a partial rescue of phytoceramide levels in avo3-30 lcb4D cells.
Alternatively, exogenous PHS could act as an independent sig-
naling molecule, as has been suggested previously (Dickson
and Lester, 2002; Liu et al., 2005b).
Ypk2 Functions Downstream of TORC2 to Regulate
Ceramide Levels
It has recently been proposed that PHS directly activates a num-
ber of protein kinases, in particular members of the AGC family of
kinases (Liu et al., 2005a). Among these, Ypk2 is known to play
a role in cell integrity and actin polarization and moreover has
been shown to be a direct target of TORC2 (Kamada et al.,
2005). Given our present results, we therefore investigated
whether Ypk2 might be involved in any of the phenotypes asso-
ciated with avo3-30 cells. First, we asked whether the phosphor-
ylation state of Ypk2 was altered in avo3-30 cells by monitoring
its mobility using SDS-PAGE and western blotting, as has been
used previously to examine the phosphorylation state of this
protein (Kamada et al., 2005). Indeed, we observed that Ypk2
was constitutively hypophosphorylated in avo3-30 cells in com-
parison to wild-type (Figure 5A). Interestingly, hypophosphoryla-
tion of Ypk2 was not affected by either deletion of LCB4 or addi-
tion of exogenous PHS, consistent with it functioning directly
downstream of TORC2 (data not shown). These observations
prompted us to examine avo3-30-specific phenotypes when
the mutant was transformed with a plasmid expressing a consti-
tutively active allele of YPK2 (YPK2D239A) (Kamada et al., 2005).
We found that expression of this allele rescued the ts phenotype
of avo3-30 cells completely at 30C, and to a lesser extent at
higher temperatures (Figure 5B). Moreover, expression of
YPK2D239A restored C24-PHS and C26-PHS ceramide levels
(p < 0.01 and p < 0.05, respectively) as well as actin polariza-
tion in avo3-30 cells (Figures 5C and 5D). From these results, we
conclude that Ypk2 acts downstream of TORC2 to regulate cer-
amide levels as well as actin polarization.
Deletion of the Calcineurin Regulatory Subunit B
Restores Ceramide Levels in avo3-30 Cells
Calcineurin is an evolutionarily conservedCa2+/calmodulin-regu-
lated protein phosphatase that has recently been identified
as a negative regulator of TORC2 activity and has also been(E) Addition of PHS partially rescues phytoceramide levels in avo3-30 and avo3-30 lcb4D cells. Cells were grown at 25C and shifted to 30C for 3 hr. PHS was
then added to a final concentration of 4 mM, and cells were incubated for an additional 3 hr at 30C. Sphingolipids were extracted, and ceramide levels were
analyzed by LC-MS/MS. Error bars indicate the SD of separately extracted samples (n = 3).Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc. 153
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of YPK2 Rescues Multiple Phenotypes of the avo3-30
Mutant
(A) WT and avo3-30 cells expressing a HA3-tagged version of
Ypk2 were grown in YPDmedium at 25C and either shifted to
30C for 3 hr or left at 25C and were then processed for west-
ern blot analysis, probing for Ypk2 using anti-HA antibody. The
asterisk indicates the phosphorylated form of Ypk2 (Kamada
et al., 2005).
(B) WT and avo3-30 cells harboring either pYE352[YPK2D239A]
or vector plasmid were streaked onto selective dropout plates
and incubated at the indicated temperatures for 3–4 days.
(C) WT and avo3-30 cells harboring either pYE352[YPK2D239A]
or vector plasmid were grown in selective dropout medium at
25C overnight, followed by a shift to 30C for 3 hr. Sphingo-
lipids were extracted and ceramide levels were analyzed by
LC-MS/MS as described in Experimental Procedures. Error
bars indicate the SD of separately extracted samples (n = 3).
(D) WT and avo3-30 cells harboring either pYE352[YPK2D239A]
or vector plasmid were grown as described in (C), fixed, and
stained for actin with rhodamine-coupled phalloidin. The
graph below shows the percentage of cells with completely
polarized actin patches.
formation of IPC (Beeler et al., 1998; Tabuchi
et al., 2006) (Figure 1). The findings presented
here significantly extend our understanding of this
regulation by demonstrating that a functional
Avo3 protein, an essential and specific component
of TORC2, is required for maintenance of normal
levels of ceramides in vivo, which in turn allows
for the synthesis of more complex sphingolipids
that are required for cell growth. Our observation
that ceramide synthesis is impaired in vitro in mi-
crosomal membranes isolated from avo3-30 cells
suggests further that the activity of ceramide syn-
thase is directly affected in this mutant. Acyl-
CoA-dependent ceramide synthase activity is car-
ried out by the highly similar Lag1 and Lac1 en-
zymes (Schorling et al., 2001; Guillas et al., 2001),reported to be a negative regulator of the synthesis of complex
sphingolipids (Mulet et al., 2006; Tabuchi et al., 2006). We there-
fore sought to determinewhether calcineurinmight also influence
TORC2 activity with respect to maintenance of ceramide levels.
Indeed, we observed that deletion of CNB1, which encodes the
calcineurin regulatory subunit B, both rescued the growth pheno-
type of avo3-30 at 30C and restored phytoceramide levels in
avo3-30 cells (p < 0.05), although not to levels observed in wild-
type cells (Figure 6). These results thus extend the antagonistic
relationship between calcineurin and TORC2 activity to include
regulation of ceramides. Interestingly, however, no improvement
in actin polarization was observed in avo3-30 cnb1D cells com-
pared to avo3-30 cells (data not shown), suggesting that regula-
tion of ceramides levels and control of actin polarization repre-
sent distinct and separable readouts of TORC2.
DISCUSSION
TORC2 has previously been implicated in the regulation of sphin-
golipid biosynthesis at a step (or steps) that occurs prior toas well as the recently characterized regulatory protein Lip1
(Vallee and Riezman, 2005). Our results now raise the
important question of whether TORC2 signaling affects one or
more of these subunits.
Concomitant with a reduction in ceramides in avo3-30 cells
are a decrease in the steady-state levels of sphingoid LCBs
and an increase in LCBPs, both of which are likely to contribute
to the impaired growth phenotype of this mutant. These findings
therefore suggest that TORC2 is likely to influence more than
simply ceramide synthase and may play a more general role in
the ‘‘ceramide/LCBP rheostat,’’ wherein the relative levels of
these components are controlled to regulate cell growth and sur-
vival in both yeast and mammals (Hannun, 1996; Kobayashi and
Nagiec, 2003; Spiegel andMilstien, 2000) (Figure 1). This conclu-
sion is consistent with the extreme phylogenetic conservation of
TORC2 as well as the fact that the initial steps of sphingolipid
biosynthesis, including ceramide formation, involve enzymes
that are conserved among eukaryotes (Obeid et al., 2002).
We suggest that TORC2 regulates ceramide biosynthesis
at least in part by signaling through the AGC kinase Ypk2
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hypophosphorylated in avo3-30 cells and that expression of
a constitutively active version of this kinase rescues both the
growth defect and ceramide levels in this mutant. We have
also found that deletion of CNB1 partially restores ceramide
levels in avo3-30 cells, demonstrating that calcineurin plays an
antagonistic role within the pathway (Figure 7A). Together, these
observations extend the results of previous studies that have
established both a positive link between TORC2 and Ypk2
(Kamada et al., 2005) and a negative link between TORC2 and
calcineurin (Mulet et al., 2006) to include regulation of ceramide
synthesis. In addition, our finding that expression of the constitu-
tively active YPK2D239A allele rescues the actin polarization de-
fect in avo3-30 cells whereas deletion of CNB1 does not argues
that actin polarization and ceramide synthesis are separable
activities regulated independently by TORC2/Ypk2 (Figure 7A).
In addition to TORC2, activation of Ypk2 requires phosphoryla-
tion by Pkh1 or Pkh2, the yeast orthologs of mammalian PDK1
Figure 6. Deletion of the Calcineurin Regulatory Subunit CNB1
Restores a Subset of the Phenotypes of the avo3-30 Mutant
(A) WT, avo3-30, avo3-30 cnb1D, and cnb1D cells were streaked onto YPD
plates and incubated at the indicated temperatures.
(B) avo3-30 and avo3-30 cnb1D cells were grown in liquid YPDmedium tomid-
log phase, sphingolipids were extracted, and ceramide levels were analyzed
by LC-MS/MS. Error bars indicate the SD of separately extracted samples
(n = 3).(Kamada et al., 2005). Indeed, dual activation of AGCkinase fam-
ily members by TOR and PDK1 is emerging as a conserved reg-
ulatory theme in eukaryotes (Powers, 2007). Interestingly, there is
also significant evidence to indicate that PHS activates Pkh1/2
and, to a lesser extent, other AGC kinases, including Ypk2 (Liu
et al., 2005a). Given our present findings, we suggest the exis-
tence of a ‘‘feed-forward’’ regulatory loop wherein PHS both
acts as a substrate and stimulates the signaling pathway directly
involved in ceramide synthesis (Figure 7B). Our observation that
addition of exogenous PHS can largely restore actin polarization
within avo3-30 cells but does not restore Ypk2 phosphorylation
or ceramide levels underscores the importance of TORC2 in
Ypk2 activation and additionally suggests that PHS must influ-
ence other routes for actin polarization downstream of Pkh1/2,
for example via activation of Pkc1 (Liu et al., 2005b) (Figure 7B).
We have identified what appears to be a distinct point of reg-
ulation compared to that described in another recent study, in
which TORC2 and its downstream effectors Slm1 and Slm2
were also linked to sphingolipid biosynthesis (Tabuchi et al.,
2006). The authors concluded that Slm1 and Slm2 negatively
regulate a later step in the pathway, carried out by Isc1, which
catalyzes a reverse reaction that catabolizes IPC back to free
ceramides (Tabuchi et al., 2006) (Figure 1). A number of other
studies have also now linked Slm1/2 to sphingolipids and/or cal-
cineurin (Bultynck et al., 2006; Daquinag et al., 2007). Impor-
tantly, a prediction of the Tabuchi et al. (2006) model is that
loss of TORC2 activity should result in elevated levels of both
PHS- and a-hydroxylated ceramides; however, as described
above, we instead observe a significant reduction in these spe-
cies within avo3-30 cells. Moreover, whereas deletion of ISC1
was observed to rescue several phenotypes associated with
Figure 7. Models Illustrating Connections between TORC2 Signal-
ing and Regulation of the Sphingolipid Biosynthetic Pathway
(A) TORC2 signals to Ypk2 to positively regulate de novo synthesis of ceram-
ides at a step that is antagonized by calcineurin.
(B) Interplay between TORC2 and PHS for activation of Ypk2 for ceramide
synthesis. See text for details.Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc. 155
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such rescue of avo3-30-specific phenotypes in an isc1D back-
ground (unpublished data). On the other hand, deletion of
CNB1 results in the partial rescue of phenotypes associated
with slm1ts/slm2D cells, in agreement with our present findings
that ceramide levels are partially restored in avo3-30 cnb1D cells
(Figure 6). Additional studies will be required to clarify the rela-
tionship between the TORC2/Ypk2 and the TORC2/Slm1/2
branches with respect to sphingolipid biosynthesis. Interest-
ingly, de novo biosynthesis of ceramides has also been identified
as a target for regulation by casein kinase II, where deletion of
CKA2, encoding the a0 catalytic subunit, results in decreased
levels of ceramides formed in microsomes in vitro (Kobayashi
and Nagiec, 2003). In yeast, casein kinase II is required for
cell-cycle progression as well as maintenance of cell polarity
(Canton and Litchfield, 2006; Hanna et al., 1995; Rethinaswamy
et al., 1998), activities also positively influenced by TOR. Thus, it
will be of interest to examinewhether TORC2 and casein kinase II
collaborate to regulate ceramide biosynthesis.
Might TORC2 regulate de novo ceramide formation in higher
eukaryotes? An apparent paradox with this suggestion is that
TORC2 acts within a pro-growth signaling network, whereas ce-
ramides are associated with promoting stress-induced growth
inhibition and apoptosis in mammalian cells (Hannun and Obeid,
2002; Obeid and Hannun, 2003; Venable et al., 1995). However,
it is important to consider that the major pathway responsible for
production of ceramides involved in apoptosis and stress-
induced signaling in mammalian cells is catabolism of sphingo-
myelin by neutral sphingomyelinase rather than de novo biosyn-
thesis (Clarke and Hannun, 2006; Posse de Chaves, 2006).
Moreover, in mammalian cells, both the major sphingoid base
sphingosine and its phosphorylated form, sphingosine-1-P, the
latter of which is positively involved in proliferation and survival
signaling, are synthesized exclusively via a ceramide recycling
pathway (Huwiler and Zangemeister-Wittke, 2007). Thus, ceram-
ide synthesis is required for the production of the entire set of
bioactive sphingolipids. Finally, an adequate level of ceramides
must be maintained in order to facilitate synthesis of more com-
plex sphingolipids, which are required for normal cell growth
(Dickson and Lester, 1999; Yamaoka et al., 2004). We speculate
that a positive role for ceramides in growth may be more appar-
ent in a rapidly dividing organism such as yeast growing under
rich nutrient conditions.
EXPERIMENTAL PROCEDURES
Yeast Strains, Media, and Antibodies
Yeast strains used in this study are listed in Table S1. Unless indicated other-
wise, cells were grown in rich YPD medium (2% yeast extract, 1% peptone,
and 2% dextrose supplemented with adenine and tryptophan at 5 mg/l). All
yeast transformations were conducted using a lithium acetate procedure
(Geitz and Woods, 1998). Construction of deletion strains by replacement of
complete open reading frames (ORFs) with a selectable marker as well as epi-
tope tagging of YPK2 was performed as described previously (Dilova et al.,
2004). Monoclonal antibodies specific for HA (12CA5) and c-Myc (9E10)
were purchased from Roche Diagnostics and Covance, respectively. Poly-
clonal antibodies specific for Tor1 were from Santa Cruz Biotechnology.
Isolation of Avo3-30
Error-prone PCR was used to generate mutations within the 30 end of chromo-
somally encoded AVO3, following previously established protocols (Muhlrad156 Cell Metabolism 7, 148–158, February 2008 ª2008 Elsevier Inc.et al., 1992; Umen and Guthrie, 1996). In a first step, error-prone PCR condi-
tions were used to amplify 1 kb of the 30 end of the AVO3 ORF using
pAVO3 (a generous gift of L. Hicke) as a template plasmid. In a second step,
standard PCR conditions were used to amplify a fragment that contained
the last 70 bp of the AVO3 ORF, followed by sequences encoding multiple
copies of the Myc epitope and the TRP1 gene, using pFA6a-13Myc-TRP1
(Longtine et al., 1998) as a template plasmid. In a third step, these two frag-
ments were fused together using SOEing (splice overlap extension) (Horton
et al., 1993) to generate a single fragment that was used to transform strain
LHY291. Transformed cells were selected for by growth on SCD agar plates
lacking tryptophan for 3–4 days at 25C. Colonies were screened for temper-
ature-sensitive growth at both 30C and 37C. Of 1856 transformants
screened, 4 displayed a strong temperature-sensitive (ts) phenotype at
37C. One of these also displayed a strong ts phenotype at 30C. This allele
was named avo3-30 and was used for the studies reported here. Genetic
backcross analyses demonstrated that this allele was recessive and segre-
gated in a 2:2 manner. In addition, the temperature-sensitive behavior of
avo3-30 was completely suppressed by transformation with pAVO3, and
western blot analysis demonstrated that avo3-30 cells produced full-length
Avo3 protein. Finally, DNA sequence analysis identified a number of predicted
amino acid substitutions throughout the last 1 kb of the 30 end of the AVO3
ORF. A full description of these mutations will be published elsewhere.
Chemicals for LC-MS/MS
DHS, PHS, DHS-P, PHS-P (all C18 species), SPHC17 base, C18:0-PHS, C16:0-
DHS, C18:0-DHS, C24:0-DHS, and C17:0-SPH ceramide standards were
purchased from Avanti Polar Lipids. C24:0-PHS and C26:0-PHS were synthe-
sized as described previously (Hwang et al., 2001; Ramjit et al., 2005) and
purified by preparative high-performance liquid chromatography. Sphingolipid
standards were dissolved in ethanol and stored at 80C.
Extraction of Lipids
All experiments were performedmultiple times, and all samples were prepared
in triplicate for each experiment. Forty A600 units of cell culture were killed by
5% trichloroacetic acid (TCA) for 10 min on ice. LCBs, LCBPs, and ceramides
were extracted as described previously (Lester and Dickson, 2001). SPHC17
base, used as internal standard, was dissolved in ethanol to a concentration
of 5 ng/ml and added to each cell pellet during extraction. Samples were trans-
ferred to autosampler vials and analyzed by LC-MS/MS.
LC-MS/MS Analysis of LCBs, LCBPs, and Ceramides
LC-MS/MS analysis of sphingolipids was performed using a Quattro Premier
tandem quadrupole mass spectrometer (Waters) coupled to an Acquity Ultra
Performance LC system (Waters). LCBs, LCBPs, and ceramides were re-
solved in a single 20 min run by reverse-phase chromatography using an Acq-
uity BEH C18 column (Waters) at a flow rate of 0.5 ml/min with a column size of
2.13 50mm and a 1.7 mmparticle size. The solvent system consisted of water
(A) and acetonitrile (B), both containing 0.1% formic acid. The initial solvent
composition was 55% solvent B. The gradient program further involved 1
min linear gradient to 65% solvent B, followed by 4.5 min linear gradient to
75% solvent B, followed by 0.5 min linear gradient to 95% solvent B held for
3 min, followed by 1 min linear gradient to 99% solvent B held for 10 min.
The column was re-equilibrated to initial conditions for 1 min.
Electrospray ionization (ESI) of sphingolipids was performed in positive
mode with capillary voltage 3 kV, source temperature 125C, and desolvation
temperature 350C using nitrogen as desolvation and cone gas. Sphingolipids
were quantitatively analyzed inmultiple reactionmonitoring (MRM)mode (spe-
cificMRMparameters are shown in Table S2 and selected ion chromatograms
in Figure S2) using 2.23 103 millibars argon as collision gas. External calibra-
tion curves of synthetic standards were built using 5–6 concentration points in
the range from 1 ng/ml to 100 mg/ml. Integration and data analysis were per-
formed using the QuantLynx module of MassLynx 4.1 software (Waters). The
level of significance of all LC-MS/MS data was determined by unpaired t test.
In Vitro Ceramide Synthesis Assay
Wild-type and avo3-30 cells were grown in YPDmedium at 25C and shifted to
30C for 6 hr. Microsomal membranes were prepared from 250 OD600 units of
each culture as described previously (Vallee and Riezman, 2005) and
Cell Metabolism
TORC2 Regulates Ceramide Biosynthesisresuspended in B88 buffer (20 mM HEPES [pH 6.8], 150 mM KAc, 5 mM
MgAc2, and 250mM sorbitol) to a protein concentration of 2 mg/ml. For in vitro
ceramide synthesis, 10 ml of protein lysate was combined in a 100 ml reaction
volume with 20 mM SPHc17 base (dissolved in a 40 mM solution of defatted
BSA) and 2–150 mM C18-CoA (dissolved in DMSO). The reactions were incu-
bated at 22C for 25 min and stopped by addition of 500 ml cold ethanol con-
taining C17-ceramide (C17-SPH) as an internal standard at a concentration of
50 ng/ml. Lipids were extracted into ethanol solution and analyzed by LC-MS/
MS. A calibration curve was constructed using C17-SPH as a standard to
quantify the product of this reaction.
Fluorescence Microscopy
Rhodamine phalloidin (Invitrogen) staining of polymerized actin was performed
essentially as described previously (Pringle et al., 1989). For experiments dem-
onstrating actin polarization at the permissive temperature, cells were grown in
YPD at 25C overnight to approximately OD600 = 0.3, followed by fixation and
staining with rhodamine phalloidin and visualization by fluorescence micros-
copy. For experiments at the nonpermissive temperature, cells were grown
in YPD at 25C overnight, diluted to approximately OD600 = 0.1 in YPD pre-
warmed to 30C with or without various concentrations of PHS, grown at
30C for various lengths of time to approximately OD600 = 0.3, and then fixed
and stained as described above. For quantification of the status of actin polar-
ization as represented by actin patch localization, approximately 100 small or
midsize budded cells were counted for each condition. Cells were considered
as having polarized actin patches if patches were concentrated in the bud and
five or fewer patches were found in the mother cell. Cells were considered as
having partially polarized patches if patches were concentrated in the bud and
there were more than five patches in the mother cell. Cells were considered
depolarized if patches were evenly distributed throughout both the bud and
mother cell. Fluorescence microscopy was performed using a Nikon E600
fluorescencemicroscope and anOrca ER charge-coupled device camera (Ha-
mamatsu) controlled by Simple PCI software. All images of actin staining are Z
series projections of optical sections.
Supplemental Data
Supplemental Data include two figures and two tables and can be found with
this article online at http://www.cellmetabolism.org/cgi/content/full/7/2/148/
DC1/.
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